Adaptive Actions and Alcohol Use Outcomes During Internet-delivered Cognitive Behaviour Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Regina

About this trial

This observational study investigates an Internet-delivered Cognitive Behaviour Therapy (ICBT) intervention for alcohol misuse, called the Alcohol Change Course Enhanced (ACCE). The intervention will be offered through the Online Therapy Unit, which is a routine care ICBT clinic. The primary objective of the study is to examine whether engagement in adaptive actions measured by the Things You Do Questionnaire (TYDQ), including healthy thinking, meaningful activities, social connections, healthy habits and goal setting - increase during ICBT for alcohol misuse. Using data collected during routine care, the relationship between adaptive actions and alcohol use will be investigated, and specifically explore if the frequency of adaptive actions increases as alcohol use reduces during the intervention.

Eligibility criteria

Qualifiers

Be a resident of Canada

Be 18 years or older

Have access to a computer or appropriate device and the internet

Endorse alcohol misuse

Disqualifiers

Current severe medical or psychiatric problem that requires immediate or alternate treatment (e.g. current and recent mania or psychosis requiring hospitalization, actively suicidal and unable to keep themselves safe, medical condition requiring immediate surgery or other invasive treatment, severe substance use, severe cognitive impairment);

Currently receiving or expecting to receive individual alcohol treatment more than twice per month

Other treatment in our clinic

Unable to read and understand English. (All content is provided in English and staff is English speaking; it is cost prohibitive at this time to provide the complete service in languages other than English)

Trial design

Treatments tested in this trial

  • Alcohol Change Course Enhanced

Treatment groups

165 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Regina

Lead sponsor

Karolinska Institutet

Collaborator

Macquarie University, Australia

Collaborator

York University

Collaborator